About InVivo Biosystems
InVivo Biosystems is a company based in United States founded in 2019.. InVivo Biosystems has raised $8.16 million across 9 funding rounds from investors including HHS, Rogue Venture Partners and Portland Seed Fund. InVivo Biosystems operates in a competitive market with competitors including Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and TransCure bioServices, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Invitro Bio Systems Private Limited
- Date of Incorporation 01 Jul, 2004
- Jurisdiction Hyderabad-27., Telangana, India
-
Annual Revenue
$2.69 M (USD)26.38as on Mar 31, 2022
-
Net Profit
$434.68 K (USD)86.15as on Mar 31, 2022
-
EBITDA
$711.17 K (USD)125.47as on Mar 31, 2022
-
Total Equity Funding
$8.16 M (USD)
in 9 rounds
-
Latest Funding Round
$296.42 K (USD), Grant
May 01, 2024
-
Investors
HHS
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of InVivo Biosystems
InVivo Biosystems has successfully raised a total of $8.16M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $296.42 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $296,420
-
First Round
First Round
(27 Feb 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Grant - InVivo Biosystems | Valuation |
investors |
|
| Jan, 2024 | Amount | Seed - InVivo Biosystems | Valuation | Rogue Venture Partners | |
| Aug, 2023 | Amount | Grant - InVivo Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InVivo Biosystems
InVivo Biosystems has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Rogue Venture Partners and Portland Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
US-based startups are accelerated and funded via venture capital support.
|
Founded Year | Domain | Location | |
|
Startup accelerator
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InVivo Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InVivo Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invivo Biosystems Comparisons
Competitors of InVivo Biosystems
InVivo Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and TransCure bioServices, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| domain | founded_year | HQ Location |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| domain | founded_year | HQ Location |
Drug response assays are performed using murine in vivo models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Invivo Biosystems
Frequently Asked Questions about InVivo Biosystems
When was InVivo Biosystems founded?
InVivo Biosystems was founded in 2019.
Where is InVivo Biosystems located?
InVivo Biosystems is headquartered in United States.
Is InVivo Biosystems a funded company?
InVivo Biosystems is a funded company, having raised a total of $8.16M across 9 funding rounds to date. The company's 1st funding round was a Grant of $1.68M, raised on Feb 27, 2019.
What is the annual revenue of InVivo Biosystems?
Annual revenue of InVivo Biosystems is $2.69M as on Mar 31, 2022.
What does InVivo Biosystems do?
InVivo Biosystems was founded in 2019 in the United States, focusing on the biotechnology sector. Animal models such as C. elegans and zebrafish are utilized for transgenic and genome editing services. Assay kits, reagents including PCR master mix, custom in-vivo testing, and toxicity testing are offered to support research operations. These services enable analytical evaluations in disease modeling and related applications.
Who are the top competitors of InVivo Biosystems?
InVivo Biosystems's top competitors include Biocytogen, Applied StemCell and GenOway.
Who are InVivo Biosystems's investors?
InVivo Biosystems has 6 investors. Key investors include HHS, Rogue Venture Partners, Portland Seed Fund, ONAMI, and Launch Oregon.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.